Loading…
Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia
Purpose The aim of this study was to determine if there is a difference between complications for totally implantable central venous catheters (ports) and tunnelled external central venous catheters (external CVCs) that result in early removal of the central venous catheter (CVC) in children and ado...
Saved in:
Published in: | Pediatric surgery international 2012-12, Vol.28 (12), p.1195-1199 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13 |
---|---|
cites | cdi_FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13 |
container_end_page | 1199 |
container_issue | 12 |
container_start_page | 1195 |
container_title | Pediatric surgery international |
container_volume | 28 |
creator | White, Alan D. Othman, Diaa Dawrant, Michael J. Sohrabi, Soroush Young, Alastair L. Squire, Roly |
description | Purpose
The aim of this study was to determine if there is a difference between complications for totally implantable central venous catheters (ports) and tunnelled external central venous catheters (external CVCs) that result in early removal of the central venous catheter (CVC) in children and adolescents with acute lymphoblastic leukaemia (ALL).
Methods
All children hospitalised between November 1996 and December 2007 with ALL who had a CVC were included retrospectively. We analysed data regarding the patient’s first CVC.
Results
We included 322 patients. 254 received a port and 68 received an external CVC. There were 102 CVC complications that required removal of the CVC prior to the completion of chemotherapy (65 in patients with ports, 37 in patients with external CVCs). Overall complications requiring CVC removal were significantly less likely to occur in the patient’s with ports (
p
|
doi_str_mv | 10.1007/s00383-012-3213-4 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1221135258</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1221135258</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13</originalsourceid><addsrcrecordid>eNp1kc1O3TAQha0KVC4_D9ANstRNNyke20mcZYX6g4TEBtaWrz3mhjrJre1QeIi-M44uIFSJjcfS-eaMPYeQT8C-AmPtWWJMKFEx4JXgICr5gaxAirbqFIg9smLQdhUTtToghyndMcaUaLqP5IALaFXXsBX5dzFsgxmzWQek9xjTnKidvUdH8SFjHE2gFsccS73HcVpkkzdYpET9FGm508GM5haHgtHJU7vpg4s4UjM6atwUMC0Oif7t84YaO2ek4XHYbqZ1MCn3lgacfxscenNM9r0JCU-e6xG5-fH9-vxXdXn18-L822VlRctz5cBzyW2t1q3lnVXKdFyCV7KpmapRWIseG0BsXQ3InVXlbCxzSvrOIIgj8mXnu43TnxlT1kNfHhnKJrB8UQPnAKLmtSro5__Qu2le1rJQTSNlLfliCDvKximliF5vYz-Y-KiB6SUrvctKl6z0kpWWpef02XleD-heO17CKQDfAalI4y3GN6PfdX0C2WSh6Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1266445421</pqid></control><display><type>article</type><title>Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia</title><source>Springer Link</source><creator>White, Alan D. ; Othman, Diaa ; Dawrant, Michael J. ; Sohrabi, Soroush ; Young, Alastair L. ; Squire, Roly</creator><creatorcontrib>White, Alan D. ; Othman, Diaa ; Dawrant, Michael J. ; Sohrabi, Soroush ; Young, Alastair L. ; Squire, Roly</creatorcontrib><description>Purpose
The aim of this study was to determine if there is a difference between complications for totally implantable central venous catheters (ports) and tunnelled external central venous catheters (external CVCs) that result in early removal of the central venous catheter (CVC) in children and adolescents with acute lymphoblastic leukaemia (ALL).
Methods
All children hospitalised between November 1996 and December 2007 with ALL who had a CVC were included retrospectively. We analysed data regarding the patient’s first CVC.
Results
We included 322 patients. 254 received a port and 68 received an external CVC. There were 102 CVC complications that required removal of the CVC prior to the completion of chemotherapy (65 in patients with ports, 37 in patients with external CVCs). Overall complications requiring CVC removal were significantly less likely to occur in the patient’s with ports (
p
< 0.001). Ports were significantly less likely to require removal prior to the end of treatment overall (
p
< 0.001) and for specific complications such as infection (
p
< 0.001) and dislodgement (
p
= 0.001). However, when adjusted for disease severity there is no difference in premature CVC removal rates.
Conclusion
When patients are risk-stratified for disease severity there is no difference in rates of CVC removal prior to completion of treatment.</description><identifier>ISSN: 0179-0358</identifier><identifier>EISSN: 1437-9813</identifier><identifier>DOI: 10.1007/s00383-012-3213-4</identifier><identifier>PMID: 23178960</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Adolescent ; Catheterization, Central Venous - adverse effects ; Catheterization, Central Venous - instrumentation ; Catheters, Indwelling - adverse effects ; Child ; Child, Preschool ; Equipment Design ; Female ; Humans ; Infant ; Male ; Medicine ; Medicine & Public Health ; Original Article ; Pediatric Surgery ; Pediatrics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy ; Retrospective Studies ; Surgery ; Young Adult</subject><ispartof>Pediatric surgery international, 2012-12, Vol.28 (12), p.1195-1199</ispartof><rights>Springer-Verlag Berlin Heidelberg 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13</citedby><cites>FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23178960$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>White, Alan D.</creatorcontrib><creatorcontrib>Othman, Diaa</creatorcontrib><creatorcontrib>Dawrant, Michael J.</creatorcontrib><creatorcontrib>Sohrabi, Soroush</creatorcontrib><creatorcontrib>Young, Alastair L.</creatorcontrib><creatorcontrib>Squire, Roly</creatorcontrib><title>Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia</title><title>Pediatric surgery international</title><addtitle>Pediatr Surg Int</addtitle><addtitle>Pediatr Surg Int</addtitle><description>Purpose
The aim of this study was to determine if there is a difference between complications for totally implantable central venous catheters (ports) and tunnelled external central venous catheters (external CVCs) that result in early removal of the central venous catheter (CVC) in children and adolescents with acute lymphoblastic leukaemia (ALL).
Methods
All children hospitalised between November 1996 and December 2007 with ALL who had a CVC were included retrospectively. We analysed data regarding the patient’s first CVC.
Results
We included 322 patients. 254 received a port and 68 received an external CVC. There were 102 CVC complications that required removal of the CVC prior to the completion of chemotherapy (65 in patients with ports, 37 in patients with external CVCs). Overall complications requiring CVC removal were significantly less likely to occur in the patient’s with ports (
p
< 0.001). Ports were significantly less likely to require removal prior to the end of treatment overall (
p
< 0.001) and for specific complications such as infection (
p
< 0.001) and dislodgement (
p
= 0.001). However, when adjusted for disease severity there is no difference in premature CVC removal rates.
Conclusion
When patients are risk-stratified for disease severity there is no difference in rates of CVC removal prior to completion of treatment.</description><subject>Adolescent</subject><subject>Catheterization, Central Venous - adverse effects</subject><subject>Catheterization, Central Venous - instrumentation</subject><subject>Catheters, Indwelling - adverse effects</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Equipment Design</subject><subject>Female</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Original Article</subject><subject>Pediatric Surgery</subject><subject>Pediatrics</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Young Adult</subject><issn>0179-0358</issn><issn>1437-9813</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp1kc1O3TAQha0KVC4_D9ANstRNNyke20mcZYX6g4TEBtaWrz3mhjrJre1QeIi-M44uIFSJjcfS-eaMPYeQT8C-AmPtWWJMKFEx4JXgICr5gaxAirbqFIg9smLQdhUTtToghyndMcaUaLqP5IALaFXXsBX5dzFsgxmzWQek9xjTnKidvUdH8SFjHE2gFsccS73HcVpkkzdYpET9FGm508GM5haHgtHJU7vpg4s4UjM6atwUMC0Oif7t84YaO2ek4XHYbqZ1MCn3lgacfxscenNM9r0JCU-e6xG5-fH9-vxXdXn18-L822VlRctz5cBzyW2t1q3lnVXKdFyCV7KpmapRWIseG0BsXQ3InVXlbCxzSvrOIIgj8mXnu43TnxlT1kNfHhnKJrB8UQPnAKLmtSro5__Qu2le1rJQTSNlLfliCDvKximliF5vYz-Y-KiB6SUrvctKl6z0kpWWpef02XleD-heO17CKQDfAalI4y3GN6PfdX0C2WSh6Q</recordid><startdate>20121201</startdate><enddate>20121201</enddate><creator>White, Alan D.</creator><creator>Othman, Diaa</creator><creator>Dawrant, Michael J.</creator><creator>Sohrabi, Soroush</creator><creator>Young, Alastair L.</creator><creator>Squire, Roly</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20121201</creationdate><title>Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia</title><author>White, Alan D. ; Othman, Diaa ; Dawrant, Michael J. ; Sohrabi, Soroush ; Young, Alastair L. ; Squire, Roly</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Catheterization, Central Venous - adverse effects</topic><topic>Catheterization, Central Venous - instrumentation</topic><topic>Catheters, Indwelling - adverse effects</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Equipment Design</topic><topic>Female</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Original Article</topic><topic>Pediatric Surgery</topic><topic>Pediatrics</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>White, Alan D.</creatorcontrib><creatorcontrib>Othman, Diaa</creatorcontrib><creatorcontrib>Dawrant, Michael J.</creatorcontrib><creatorcontrib>Sohrabi, Soroush</creatorcontrib><creatorcontrib>Young, Alastair L.</creatorcontrib><creatorcontrib>Squire, Roly</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric surgery international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>White, Alan D.</au><au>Othman, Diaa</au><au>Dawrant, Michael J.</au><au>Sohrabi, Soroush</au><au>Young, Alastair L.</au><au>Squire, Roly</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia</atitle><jtitle>Pediatric surgery international</jtitle><stitle>Pediatr Surg Int</stitle><addtitle>Pediatr Surg Int</addtitle><date>2012-12-01</date><risdate>2012</risdate><volume>28</volume><issue>12</issue><spage>1195</spage><epage>1199</epage><pages>1195-1199</pages><issn>0179-0358</issn><eissn>1437-9813</eissn><abstract>Purpose
The aim of this study was to determine if there is a difference between complications for totally implantable central venous catheters (ports) and tunnelled external central venous catheters (external CVCs) that result in early removal of the central venous catheter (CVC) in children and adolescents with acute lymphoblastic leukaemia (ALL).
Methods
All children hospitalised between November 1996 and December 2007 with ALL who had a CVC were included retrospectively. We analysed data regarding the patient’s first CVC.
Results
We included 322 patients. 254 received a port and 68 received an external CVC. There were 102 CVC complications that required removal of the CVC prior to the completion of chemotherapy (65 in patients with ports, 37 in patients with external CVCs). Overall complications requiring CVC removal were significantly less likely to occur in the patient’s with ports (
p
< 0.001). Ports were significantly less likely to require removal prior to the end of treatment overall (
p
< 0.001) and for specific complications such as infection (
p
< 0.001) and dislodgement (
p
= 0.001). However, when adjusted for disease severity there is no difference in premature CVC removal rates.
Conclusion
When patients are risk-stratified for disease severity there is no difference in rates of CVC removal prior to completion of treatment.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>23178960</pmid><doi>10.1007/s00383-012-3213-4</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0179-0358 |
ispartof | Pediatric surgery international, 2012-12, Vol.28 (12), p.1195-1199 |
issn | 0179-0358 1437-9813 |
language | eng |
recordid | cdi_proquest_miscellaneous_1221135258 |
source | Springer Link |
subjects | Adolescent Catheterization, Central Venous - adverse effects Catheterization, Central Venous - instrumentation Catheters, Indwelling - adverse effects Child Child, Preschool Equipment Design Female Humans Infant Male Medicine Medicine & Public Health Original Article Pediatric Surgery Pediatrics Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Retrospective Studies Surgery Young Adult |
title | Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T17%3A15%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Implantable%20versus%20cuffed%20external%20central%20venous%20catheters%20for%20the%20management%20of%20children%20and%20adolescents%20with%20acute%20lymphoblastic%20leukaemia&rft.jtitle=Pediatric%20surgery%20international&rft.au=White,%20Alan%20D.&rft.date=2012-12-01&rft.volume=28&rft.issue=12&rft.spage=1195&rft.epage=1199&rft.pages=1195-1199&rft.issn=0179-0358&rft.eissn=1437-9813&rft_id=info:doi/10.1007/s00383-012-3213-4&rft_dat=%3Cproquest_cross%3E1221135258%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1266445421&rft_id=info:pmid/23178960&rfr_iscdi=true |